Skip to main content

Table 1 Distribution of clinical features between ATRX mutant and wild patients

From: The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity

Characteristics

Classification

ATRX mutant type

ATRX wild type

χ2

P value

MSI status

MSI-H

13

62

19.317

< 0.001

MSS

6

246

  

MSI-L

3

49

  

Age

≤ 65

8

181

0.867

0.325

>  65

15

224

  

Sex

Female

19

135

23.475

< 0.001

Male

4

275

  

Grade

G1

0

12

10.564

0.010

G2

2

156

  

G3

20

234

  

GX

1

8

  

Stage

Stage I

4

52

2.045

0.724

Stage II

9

120

  

Stage III

7

172

  

Stage IV

2

41

  

Unknown

1

25

  

T

T1

0

23

4.301

0.314

T2

5

85

  

T3

15

180

  

T4

3

113

  

TX

0

9

  

M

M0

21

360

0.902

1.000

M1

1

29

  

MX

1

21

  

N

N0

10

118

10.024

0.029

N1

5

112

  

N2

7

76

  

N3

0

86

  

NX

1

16

  
  1. MSI-H Microsatellite instability-high, MSS Microsatellite stability, MSI-L Microsatellite instability-low
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us